NCT05384145 Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
| NCT ID | NCT05384145 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Alabama at Birmingham |
| Condition | HIV |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2024-03-27 |
| Primary Completion | 2027-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2024-03-27 with a primary completion date of 2027-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to adapt and evaluate a combination intervention that includes: (1) a data-driven approach to directed community-based HIV testing to areas with high need, (2) Project Connect to expedite linkage to care at time of diagnosis, (3) and a Rapid ART (antiretroviral therapy)Start program, all in Mobile County Health Department (MCHD) jurisdictions in Alabama.
Eligibility Criteria
Inclusion Criteria: * AIM 1 \& 3: * Fit into one of the following categories: 1\) MCHD leadership, 2) ADPH leadership, 3) clinic administrators, 4) outreach testing specialists, 5) linkage coordinators and community health workers, 6) physicians, 7) nurses, 8) counselors all working at HIV care facilities in the six MCHD jurisdiction counties. * Over the age of 18 years old. AIM 2: (IDIs) * Over the age of 13 years old * Tested for HIV in MCHD jurisdiction from time of COASTAL implementation to 36 months post-implementation start date. Exclusion Criteria: * Exclusion criteria include unwillingness or inability to provide informed consent.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05384145 clinical trial?
This trial is open to participants of all sexes, aged 13 Years or older, studying HIV. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05384145 currently recruiting?
Yes, NCT05384145 is actively recruiting participants. Contact the research team at marielparman@uabmc.edu for enrollment information.
Where is the NCT05384145 trial being conducted?
This trial is being conducted at Birmingham, United States.
Who is sponsoring the NCT05384145 clinical trial?
NCT05384145 is sponsored by University of Alabama at Birmingham. The trial plans to enroll 80 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.